AVEO PHARMACEUTICALS, INC. Annual Return On Equity in % from 2012 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2021.
  • Aveo Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2022 was -81.7 %, a 22.3% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Return On Equity for 2021 was -92.8 %, a 14.9% increase from 2020.
  • Aveo Pharmaceuticals, Inc. annual Return On Equity for 2020 was -109 %, a 148% decline from 2019.
  • Aveo Pharmaceuticals, Inc. annual Return On Equity for 2019 was 225 %, a 1837% increase from 2018.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 -92.8 +16.2 +14.9% Jan 1, 2021 Dec 31, 2021
2020 -109 -334 -148% Jan 1, 2020 Dec 31, 2020
2019 225 +214 +1837% Jan 1, 2019 Dec 31, 2019
2018 11.6 -249 -95.5% Jan 1, 2018 Dec 31, 2018
2017 261 +803 Jan 1, 2017 Dec 31, 2017
2016 -543 -453 -505% Jan 1, 2016 Dec 31, 2016
2015 -89.7 +37.4 +29.4% Jan 1, 2015 Dec 31, 2015
2014 -127 -21.5 -20.4% Jan 1, 2014 Dec 31, 2014
2013 -105 -31.2 -42% Jan 1, 2013 Dec 31, 2013
2012 -74.3 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.